Medical Evidence Blog

This is discussion forum for physicians, researchers, and other healthcare professionals interested in the epistemology of medical knowledge, the limitations of the evidence, how clinical trials evidence is generated, disseminated, and incorporated into clinical practice, how the evidence should optimally be incorporated into practice, and what the value of the evidence is to science, individual patients, and society.

Showing posts with label pirfenidone. Show all posts
Showing posts with label pirfenidone. Show all posts
Monday, May 19, 2014

Sell Side Bias and Scientific Stockholm Syndrome: A Report from the Annual Meeting of the American Thoracic Society

›
What secrets lie inside? Analysts working on Wall Street are sometimes categorized as working on either the "buy side" or the...
2 comments:
Tuesday, February 3, 2009

Cost: The neglected adverse event / side effect in trials of for-profit pharmaceuticals and devices

›
Amid press releases and conference calls today pertaining to the release of data on two trials of the investigational drug pirfenidone, one ...
3 comments:
›
Home
View web version

About Me

My photo
Scott K. Aberegg, M.D., M.P.H.
Professor of Medicine, University of Utah. Former affiliations: Outside Hospital x 7.5 years; Assistant Professor, The Ohio State University; Fellowship & MPH: Johns Hopkins Hospital & Bloomberg School of Public Health, Baltimore, MD; Residency: The University of New Mexico Health Sciences Center; MD: The Ohio State University; BA, Spanish: Miami University, Ohio. All views are my own with NO institutional endorsement.
View my complete profile
Powered by Blogger.